128 related articles for article (PubMed ID: 60672)
1. Letter: Neutrophil function and myeloperoxidase activity in inflammatory bowel disease.
Renz M; Ward M; Eastwood MA; Harkness RA
Lancet; 1976 Sep; 2(7985):584. PubMed ID: 60672
[No Abstract] [Full Text] [Related]
2. Enhanced metabolic activity by polymorphonuclear leukocytes from patients with active inflammatory bowel disease.
Lamster IB; Sonis ST; Wilson RE; Falchuk ZM
Surg Forum; 1979; 30():362-4. PubMed ID: 538634
[No Abstract] [Full Text] [Related]
3. [The metabolic and phagocytic activities of the neutrophilic granulocytes in patients with nonspecific ulcerative colitis nd Crohn's disease].
Blazhenko IL; Bychkova NG; Shvets NI
Vrach Delo; 1990 Jun; (6):61-2. PubMed ID: 2399726
[TBL] [Abstract][Full Text] [Related]
4. [The dynamic phagocytic and metabolic activities of the neutrophilic granulocytes in patients with nonspecific ulcerative colitis and Crohn's disease under the influence of immunocorrective therapy].
Blazhenko IL; Kucher ND
Vrach Delo; 1991 Jan; (1):70-2. PubMed ID: 2011899
[No Abstract] [Full Text] [Related]
5. [Neutrophil NADH oxidase and myeloperoxidase activity in psoriasis].
Miklaszewska M; Wasik F
Przegl Dermatol; 1981; 68(4):441-5. PubMed ID: 6276927
[No Abstract] [Full Text] [Related]
6. Release of leukotriene B4 and 5-hydroxyeicosatetraenoic acid during phagocytosis of artificial immune complexes by peripheral neutrophils in chronic inflammatory bowel disease.
Nielsen OH; Elmgreen J; Thomsen BS; Ahnfelt-Rønne I; Wiik A
Clin Exp Immunol; 1986 Aug; 65(2):465-71. PubMed ID: 3024887
[TBL] [Abstract][Full Text] [Related]
7. [Myeloperoxidase activity and the digestive capacity of the neutrophils in acute myeloblastic leukemia].
Potapova SG; Martynova VA
Probl Gematol Pereliv Krovi; 1979 Jan; 24(1):39-44. PubMed ID: 216988
[No Abstract] [Full Text] [Related]
8. Involvement of myeloperoxidase in the metabolic activation of phagocytes: EPR studies.
Rotilio G; Brunori M; Concetti A; Dri P; Patriarca P
FEBS Lett; 1977 Feb; 73(2):181-4. PubMed ID: 190034
[No Abstract] [Full Text] [Related]
9. [Study on serum secretory IgA and dimeric IgA in inflammatory bowel disease].
Ikeda H
Nihon Shokakibyo Gakkai Zasshi; 1987 Oct; 84(10):2314-22. PubMed ID: 3437554
[No Abstract] [Full Text] [Related]
10. Neutrophil and eosinophil granule proteins as markers of response to local prednisolone treatment in distal ulcerative colitis and proctitis.
Sangfelt P; Carlson M; Thörn M; Lööf L; Raab Y
Am J Gastroenterol; 2001 Apr; 96(4):1085-90. PubMed ID: 11316151
[TBL] [Abstract][Full Text] [Related]
11. The effect of antiarthritic drugs and related compounds on the human neutrophil myeloperoxidase system.
Matheson NR
Biochem Biophys Res Commun; 1982 Sep; 108(1):259-65. PubMed ID: 6293483
[No Abstract] [Full Text] [Related]
12. [Myeloperoxidase of neutrophil leukocytes].
Shafran MG
Usp Sovrem Biol; 1981; 92(3):365-79. PubMed ID: 6278791
[No Abstract] [Full Text] [Related]
13. Plasma transforming growth factor-beta1 level in inflammatory bowel disease.
Kiliç ZM; Ayaz S; Ozin Y; Nadir I; Cakal B; Ulker A
Turk J Gastroenterol; 2009 Sep; 20(3):165-70. PubMed ID: 19821197
[TBL] [Abstract][Full Text] [Related]
14. The measurement of neutrophil myeloperoxidase by flow cytochemistry is influenced by the pseudoperoxidase activity of hemoglobin.
Hewitt J; Reardon DM
Blood; 1991 Oct; 78(7):1891. PubMed ID: 1655119
[No Abstract] [Full Text] [Related]
15. Influence of yeast mannan on release of myeloperoxidase by human neutrophils: determination of structural features of mannan required for formation of myeloperoxidase-mannan-neutrophil complexes.
Wright CD; Bowie JU; Nelson RD
Infect Immun; 1984 Feb; 43(2):467-71. PubMed ID: 6319284
[TBL] [Abstract][Full Text] [Related]
16. Abnormal neutrophil myeloperoxidase from a patient with chronic myelocytic leukemia.
Atkin CL; Andersen MR; Eyre HJ
Arch Biochem Biophys; 1982 Mar; 214(1):284-92. PubMed ID: 6282222
[No Abstract] [Full Text] [Related]
17. Comparison of myeloperoxidase activity in leukocytes from normal subjects and patients with chronic granulomatous disease.
Pegram PS; DeChatelet LR; McCall CE
J Infect Dis; 1978 Nov; 138(5):699-702. PubMed ID: 213506
[TBL] [Abstract][Full Text] [Related]
18. Interaction of human alpha-1-proteinase inhibitor with neutrophil myeloperoxidase.
Matheson NR; Wong PS; Schuyler M; Travis J
Biochemistry; 1981 Jan; 20(2):331-6. PubMed ID: 6258636
[No Abstract] [Full Text] [Related]
19. Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content.
Verspaget HW; Peña AS; Weterman IT; Lamers CB
Gut; 1988 Feb; 29(2):223-8. PubMed ID: 2831119
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil myeloperoxidase: a simple, reproducible technique to determine activity.
Kitahara M; Simonian Y; Eyre HJ
J Lab Clin Med; 1979 Feb; 93(2):232-7. PubMed ID: 219116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
